N/A
Completed N=113
Virtual Reality Distraction for Reduction
Source: ClinicalTrials.gov NCT04416555 ↗Enrolled (actual)
113
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcomePrimary: Pain Scores (Numerical Rating Scale) — 3.4; 3.5 score on a scale — p=0.391
Summary
Using a randomized controlled design, the investigators goal is to estimate the effect of VR on postoperative analgesia and opioid consumption.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Scores (Numerical Rating Scale) |
3.4; 3.5 | 0.391 |
| SECONDARY Total Opioid Consumption |
6.8; 5.7 | 0.608 |
| SECONDARY Time Weighted Average Pain Score |
4.3; 4.4 | 0.768 |
| SECONDARY Perception of Video System Usability |
75; 70 | 0.244 |
| SECONDARY Post Discharge Analgesia. |
67; 58 | 0.191 |
Eligibility Criteria
Inclusion Criteria
- American Society of Anesthesiology Physical Status 1-3;
- Scheduled for elective, primary total hip arthroplasty;
- Anticipated hospitalization of at least 1 night;
- Expected to require parenteral opioids for postoperative pain;
- Able to use IV PCA systems.
Exclusion criteria
- History of chronic pain or care by a pain management specialist;
- Use of more than 30 mg/day of oral oxycodone (or equivalent);
- Greater than 12 weeks of current and continued opioid use;
- History of seizures, epilepsy, motion sickness, stroke, dementia;
- Non-English speaking;
- Women who are pregnant or breastfeeding;
- History of substance use disorder.
Data sourced from ClinicalTrials.gov (NCT04416555). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.